Earnings Call · Q4 FY2021·2022-03-02

Q4 21EPS -63.16%·Rev n/aQ3 21EPS +20.47%·Rev n/aQ2 21EPS -26.62%·Rev n/aQ1 21EPS -14.78%·Rev n/a⚠ consensus missing

Zai Lab Ltd ZLAB

Billy Cho — Executive or Senior Management (likely CFO or Head of IR)

Samantha Du — CEO

Alan Sandler — Executive or Senior Management (likely Head of Oncology or similar)

Harald Reinhart — Executive or Senior Management (likely Head of Autoimmune & Infectious Diseases or similar)

0.0%1d on move date−1.9% vs SPY3d−22.9%5d−30.1%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ZLAB calls or request research access.

More ZLAB calls Browse calls Request research access